Targeted therapies of HER2-positive gastric adenocarcinoma

被引：1
|
作者：
Schulze, Arik Bernard [1 ]
Kerkhoff, Andrea [1 ]
Lenz, Georg [1 ]
Kessler, Torsten [1 ]
机构：
[1] Univ Hosp Muenster, Dept Med A Hematol Oncol & Pneumol, Munster, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2017年 / 6卷
关键词：
TRASTUZUMAB EMTANSINE; 2ND-LINE TREATMENT; OPEN-LABEL; PHASE-III; CANCER; LAPATINIB; TRIAL; CAPECITABINE;
D O I：
10.21037/tcr.2017.09.03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S177 / S180
页数：4
相关论文
共 50 条
  • [31] TARGETED THERAPIES HER2-positive breast cancer-sifting through many good options
    Krop, Ian E.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (06) : 312 - 313
  • [32] Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer
    Cao, Yi
    Li, Yunjin
    Liu, Ruijie
    Zhou, Jianhua
    Wang, Kuansong
    CANCERS, 2023, 15 (09)
  • [33] Systemic Therapies for HER2-Positive Advanced Breast Cancer
    Angelis, Vasileios
    Okines, Alicia F. C.
    CANCERS, 2024, 16 (01)
  • [34] HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
    Liu, Zimin
    Shi, Mingpeng
    Li, Xiaoxiao
    Song, Shanai
    Liu, Ning
    Du, Haiwei
    Ye, Junyi
    Li, Haiyan
    Zhang, Zhou
    Zhang, Lu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) : 1315 - 1324
  • [35] HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
    Zimin Liu
    Mingpeng Shi
    Xiaoxiao Li
    Shanai Song
    Ning Liu
    Haiwei Du
    Junyi Ye
    Haiyan Li
    Zhou Zhang
    Lu Zhang
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1315 - 1324
  • [36] The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer
    Jiang, Lei
    Zhao, Xingwang
    Li, Yilin
    Hu, Yajie
    Sun, Yu
    Liu, Shengde
    Zhang, Zizhen
    Li, Yanyan
    Feng, Xujiao
    Yuan, Jiajia
    Li, Jian
    Zhang, Xiaotian
    Chen, Yang
    Shen, Lin
    IUBMB LIFE, 2024, 76 (07) : 420 - 436
  • [37] The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
    Diogo Mendes
    Carlos Alves
    Noémia Afonso
    Fátima Cardoso
    José Luís Passos-Coelho
    Luís Costa
    Sofia Andrade
    Francisco Batel-Marques
    Breast Cancer Research, 17
  • [38] HER2-targeting ADC containing cleavable linker for targeted therapy of HER2-positive gastric cancer.
    Shin, S.
    Park, Y.
    Park, S.
    Ju, E.
    Ko, E.
    Chung, C.
    Song, S.
    Jeong, S.
    Choi, E.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [39] The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer - a systematic review
    Mendes, Diogo
    Alves, Carlos
    Afonso, Noemia
    Cardoso, Fatima
    Passos-Coelho, Jose Luis
    Costa, Luis
    Andrade, Sofia
    Batel-Marques, Francisco
    BREAST CANCER RESEARCH, 2015, 17
  • [40] Dual HER2-targeted approaches in HER2-positive breast cancer
    Ahn, Eugene R.
    Vogel, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 371 - 383
12345